Crossmark

Gut microbiome influences efficacy of Endostatin combined with PD-1 blockade against colorectal cancer

Published Online: 2024-09-10

Authors

Xu, Jie

Tian, Yaomei https://orcid.org/0000-0002-8979-7970
Zhao, Binyan

Hu, Die

Wu, Siwen

ma, Jing

Yang, Li https://orcid.org/0000-0002-7880-2113
License Information

Text and Data Mining valid from 2024-09-10

Version of Record valid from 2024-09-10
More Information

Article History

Received: 10 May 2024

Accepted: 13 August 2024

First Online: 10 September 2024

Declarations

:

: The animal research protocol of this study was approved by the Animal Ethics Committee of the National Key Laboratory of Biological Therapy of Sichuan University. The APPROVAL NUMBER for animal experiment in ethic approval is 20220531061.

: Not applicable.

: The authors have declared that no competing interest exists.

Document is current